Tranexamic Acid
FDA Label NDC 50090-4530

33 label sections · Submitted to the FDA by A-s Medication Solutions · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by A-s Medication Solutions for the product Tranexamic Acid (NDC 50090-4530). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 recommended dosage, 2.2 recommended dosage for patients with varying degrees of renal impairment*, 3 dosage forms and strengths, 4 contraindications, 5.1 thromboembolic risk, 5.2 risk of medication errors due to incorrect route of administration, 5.3 seizures, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Storage

Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Manufactured for: Manufactured for: X-GEN Pharmaceuticals, Inc. Big Flats NY, 14814

* Please review the disclaimer below.